Where can I buy gilteritinib from the manufacturer?

Gilteritinib is an oral drug that inhibits signaling pathways and induces cell death. For the treatment of adult patients with relapsed or refractory acute myeloid leukemia(AML)with FLT3 mutations detected by an FDAapproved test.

Giritinib was developed byAstellas Pharma and was approved for marketing by the U.S.FDA in November 2019. Giritinib was approved for marketing in China on January 31, 2021, but it has not yet been included in medical insurance. It cannot be reimbursed. The current domestic retail price is 40mg*21 tablets*2board258,000yuan. There are generic versions of this drug in Laos. The officially marketed version has government approval. The retail price of 40mg90 tablets is about 4000 yuan. Patients can choose the version according to their own financial situation.

If patients need this medicine, they can buy it from local hospital pharmacies if it is imported from China. If patients consider the economy, they can choose the version officially marketed in Laos. The first patient can go to Laos to buy the drug on his own, and the second patient can buy giritinib through regular domestic channels. The pharmaceutical factory arranges it directly, and the quality of the drug and all aspects are guaranteed.

The most common adverse reactions of giritinib (≥20%) are increased transaminase, myalgia, joint pain, fatigue and discomfort, fever, mucositis, edema, rash, non-infectious diarrhea, dyspnea, nausea, cough, constipation, eye disease, headache, dizziness, hypotension, vomiting and renal damage. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0